Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?

Suppr

超能文献

作者信息

Santen Richard J

出版信息

Womens Health (Lond). 2008 May;4(3):207-10. doi: 10.2217/17455057.4.3.207.

DOI:10.2217/17455057.4.3.207

PMID:19072467

Abstract

摘要

相似文献

Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?

Womens Health (Lond). 2008 May;4(3):207-10. doi: 10.2217/17455057.4.3.207.

Dose and duration of hormone use: understanding the effects of combined menopausal hormones on breast cancer better, 1976-2004.

J Epidemiol Community Health. 2005 Dec;59(12):1078-9. doi: 10.1136/jech.2005.035147.

Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.

Lancet Oncol. 2005 Oct;6(10):736; author reply 737. doi: 10.1016/S1470-2045(05)70365-X.

[HRT debate (hormone replacement therapy in menopause)].

Bull Cancer. 2000 Jul;87(7-8):522-4.

Hormone replacement therapy and the risk of breast cancer.

Eur J Cancer. 2008 Nov;44(16):2344-9. doi: 10.1016/j.ejca.2008.07.041. Epub 2008 Sep 8.

The impact of hormone replacement therapy on the incidence of breast cancer in Norway.

J Clin Oncol. 2005 May 20;23(15):3636-7; author reply 3637-8. doi: 10.1200/JCO.2005.05.378.

Postmenopausal hormone therapy and breast cancer.

Prescrire Int. 2009 Apr;18(100):66-7.

Breast cancer and hormone-replacement therapy: the Million Women Study.

Lancet. 2003 Oct 18;362(9392):1328; author reply 1330-1. doi: 10.1016/S0140-6736(03)14590-4.

[The role of progestin in menopausal hormonal replacement therapy].

Duodecim. 1996;112(12):1097-103.

Breast cancer and hormone-replacement therapy: the Million Women Study.

Lancet. 2003 Oct 18;362(9392):1330; author reply 1330-1. doi: 10.1016/S0140-6736(03)14593-X.

引用本文的文献

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

JAMA Netw Open. 2025 Jul 1;8(7):e2519236. doi: 10.1001/jamanetworkopen.2025.19236.

Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.

JNCI Cancer Spectr. 2018 Aug 11;2(3):pky034. doi: 10.1093/jncics/pky034. eCollection 2018 Jul.

Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.

PLoS One. 2016 Mar 24;11(3):e0151182. doi: 10.1371/journal.pone.0151182. eCollection 2016.

SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS.

Endocr Pract. 2015 Sep;21(9):1040-5. doi: 10.4158/EP15733.OR. Epub 2015 Jun 29.

Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1038-48. doi: 10.1158/1055-9965.EPI-12-0043. Epub 2012 May 14.

Hormone replacement therapy and the risk of breast cancer.

Nat Rev Clin Oncol. 2011 Aug 2;8(11):669-76. doi: 10.1038/nrclinonc.2011.110.

How to judge the association of postmenopausal hormone therapy and the risk of breast cancer.

Front Med China. 2010 Sep;4(3):290-3. doi: 10.1007/s11684-010-0093-7. Epub 2010 Aug 5.

Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues.

Brain Res. 2011 Mar 16;1379:119-36. doi: 10.1016/j.brainres.2010.11.081. Epub 2010 Dec 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验